 PHASE I, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED DOSE DE-ESCALATION STUDY TO EVALUATE SAFETY AND IMMUNOGENICITY OF ALUM ADJUVANTED ZIKA VIRUS PURIFIED INACTIVATED VACCINE ZPIV IN ADULTS IN A FLAVIVIRUS ENDEMIC AREA: 